C
Covid-19, Protein Subunit Vaccine [Nuvaxovid]
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
No
Post-marketing information
Dear Healthcare Professional Letters
Subsidy Information and Financing Scheme
No
Active ingredients: Covid-19, Protein Subunit Vaccine | Covid-19 Vaccine | Vaccine Covid-19
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
Not Applicable
Post Marketing Information
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Intramuscular
NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µG/DOSE (RECOMBINANT, ADJUVANTED) [SIN16886P]*
* Clinical information is available for this product.